as on October 14, 2025 at 1:29 am IST
Day's Low
Day's High
2.76%
Downside
6.21%
Upside
52 Week's Low
52 Week's High
34.48%
Downside
440.69%
Upside
Check China Sxt Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$171.5M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
3864200.00%
Compare market cap, revenue, PE, and other key metrics of China Sxt Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
NA | $171.5M | -99.97% | NA | -189.77% | |
BUY | $19.9B | NA | 17.16 | 40.36% | |
BUY | $40.6B | NA | 20 | 13.81% | |
BUY | $13.6B | 35.95% | 40.64 | 13.88% | |
BUY | $63.0B | -13.08% | 24.53 | 27.83% |
The China Sxt Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
China Sxt Pharmaceuticals Inc investment value today
Current value as on today
₹37,900
Returns
Returns from China Sxt Pharmaceuticals Inc Stock
Dollar Returns*
₹5,606 (+5.61%)
Search interest for China Sxt Pharmaceuticals Inc Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:16% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 414.74K → 455.70K (in $), with an average increase of 4.5% per quarter
Against Peers
In the last 1 year, United Therapeutics Corporation has given 23.2% return, outperforming this stock by 90.9%
Against Peers
In the last 3 years, United Therapeutics Corporation has given 103.3% return, outperforming this stock by 202.2%
Profit Down
Netprofit is down for the last 4 quarters, 3.29M → -1.25M (in $), with an average decrease of 107.9% per quarter
Price Dip
In the last 7 days, SXTC stock has moved down by -11.6%
Organisation | China Sxt Pharmaceuticals Inc |
Headquarters | 178 Taidong Road North, Taizhou, China, 225300 |
Industry | Health Technology |
CEO | Mr. Feng Zhou |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Feng Zhou | Chairman of the Board & Co-CEO |
Mr. Sze Beng Lim | Co-Chief Executive Officer |
Mr. Xiaodong Pan | Chief Financial Officer |
Mr. Jun Zheng | Executive Director |
China Sxt Pharmaceuticals Inc share price today is $1.45 as on at the close of the market. China Sxt Pharmaceuticals Inc share today touched a day high of $1.54 and a low of $1.41.
China Sxt Pharmaceuticals Inc share touched a 52 week high of $7.84 on and a 52 week low of $0.95 on . China Sxt Pharmaceuticals Inc stock price today i.e. is closed at $1.45,which is 81.51% down from its 52 week high and 52.63% up from its 52 week low.
China Sxt Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in China Sxt Pharmaceuticals Inc (SXTC) shares with as little as ₹88.635 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in China Sxt Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on China Sxt Pharmaceuticals Inc share’s latest price of $1.45 as on October 14, 2025 at 1:29 am IST, you will get 6.8966 shares of China Sxt Pharmaceuticals Inc. Learn more about
fractional shares .
China Sxt Pharmaceuticals Inc stock has given -99.97% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?